Maturation of dendritic cells from ovarian cancer patients

Cancer Chemotherapy and Pharmacology

Volumn 48, Issue 4, 2001, Pages 289-296

  Hájek, Milan ^a   Burian, Martin ^a   Dezortová, Monika ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Dendritic cells; Ovarian cancer; Polyenzyme preparation

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CHYMOTRYPSIN; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 4; PAPAIN; PROTEINASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; ASCITES; BLOOD SAMPLING; CANCER PATIENT; CELL MATURATION; CELL STIMULATION; CELL SURFACE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE CULTURE; MIXED LYMPHOCYTE REACTION; MONOCYTE; OVARY CARCINOMA; PERITONEAL CAVITY; PERITONEUM CANCER; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE CULTURE;

ADULT; AGED; ASCITES; CELL DIFFERENTIATION; CULTURE MEDIA; CYTOKINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PEPTIDE HYDROLASES; TUMOR CELLS, CULTURED;

EID: 0034846733     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800100331     Document Type: Article

References (21)

1. TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow antigen-presenting cells for both naive and primed T cells
2. Cancer statistics
3. + cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells
4. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
5. Serum concentrations of soluble TNF-alpha receptors and β2-microglobulin in multiple myeloma patients after immunochemotherapy
6. Intraperitoneal immunotherapy of peritoneal carcinomatosis
7. Decreased antigen presentation by dendritic cells in patients with breast cancer
8. Physical and chemical properties of human plasma alpha2-macroglobulin
9. Selective modulation of cell adhesion molecules on lymphocytes by bromelain protease 5
10. Identification of an IL-10 producing HLA-DR negative monocyte subset in the malignant ascites of patients with ovarian carcinoma which inhibits cytokine protein expression and proliferation of autologous T cells
11. + cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis
12. Dendritic cells: A link between innate and adaptive immunity
13. Survival analysis of an adjuvant therapy with oral enzymes in multiple myeloma patients
14. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients
15. Induction of tolerance by IL-10-treated dendritic cells
16. Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastasis in mice
17. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow
18. Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation
19. The role of macrophages in antitumor defense of patients with ovarian cancer
20. Transforming growth factor-β1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway
21. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily